Abstract
We have previously reported that naloxone, a nonspecific opioid receptor antagonist, suppresses alcohol but not water consumption by male rats that have been genetically selected for high voluntary alcohol drinking. However, the identity of the specific opioid receptor subtype that may mediate alcohol drinking is not known. This paper reports that a selective delta opioid receptor antagonist is as effective as naloxone in suppressing alcohol consumption and that an enkephalinase inhibitor, which potentiates the action of endogenous enkephalins, increases alcohol intake. These results suggest that alcohol-induced activation of the endogenous enkephalinergic system, and occupation of delta opioid receptors, are involved in the maintenance of continued alcohol drinking.
Similar content being viewed by others
References
Altshuler HI, Phillips PE, Feinhandler DA (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26:679–688
Bayon A, Shoemaker WJ, McGinty JF, Bloom F (1983) Immunodetection of endorphins and enkephalins: a search for reliability. Int Rev Neurobiol 24:51–92
Blum K, Elston SFA, DeLallo L, Briggs AH, Wallace JE (1983) Ethanol acceptance as a function of genotype amounts of brain (met) enkephalin. Proc Natl Acad Sci USA 80:6510–6512
Blum K, Briggs AH, Trachtenberg MC, DeLallo L, Wallace JE (1987) Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice. Alcohol 6:449–456
Chang KJ, Cuatrecasas P (1981) Heterogeneity and properties of opiate receptors. Fed Proc 40:2729–2734
Chang KJ, Cooper BR, Hazum E, Cuatrecasas P (1979) Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol 16:91–104
Chang KJ, Hazum E, Killian A, Cuatrecasas P (1981) Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. Mol Pharmacol 20:1–7
Chang KJ, Blanchard SG, Cuatrecasas P (1984) Benzomorphan sites are ligand recognition sites of putative e-receptors. Mol Pharmacol 26:484–488
Chavkin C, James IF, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215:413–415
Cheng SS, Tseng LF (1982) Chronic administration of ethanol on pituitary and hypothalamicβ-endorphin in rats and golden hamsters. Pharmacol Res Commun 14:1001–1008
Childers SR, Creese I, Snowman AM, Snyder SH (1979) Opiate receptor binding affected differentially by opiates and opioid peptides. Eur J Pharmacol 55:11–18
Chipkin RE, Latranyi MB, Iorio LC (1982) Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone. Life Sci 31:1189–1192
Cotton R, Giles MG, Miller L, Shaw JS, Timms D (1984) ICI 174864: a highly selective antagonist for the opioid delta receptor. Eur J Pharmacol 97:331–332
Cowan A, Zhu XZ, Porreca F (1985) Studies in vivo with ICI 174864 and (d-Pen2,d-Pen5) enkephalin. Neuropeptides 5:311–314
Cox BM (1982) Endogenous opioid peptides: a guide to structures and terminology. Life Sci 31:1645–1658
Cox BM (1985) Peptide biosynthesis. Alcohol Drug Res 6:85–86
Ehrenpreis S (1982)d-Phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application. Substance and Alcohol Actions/Misuse 3:231–239
Froehlich JC, Li T-K (1990) Enkephalinergic involvement in voluntary alcohol drinking. In: Reid L (ed) Opioids, bulimia, alcohol abuse and alcoholism. Springer-Verlag, New York, pp 217–228
Froehlich JC, Harts J, Lumeng L, Li T-K (1988) Enkephalinergic involvement in voluntary ethanol consumption. Excerpta Medical International Congress Series 805:235–238
Frohelich JC, Harts J, Lumeng L, Li T-K (1990) Naloxone attenuates ethanol intake in rats selectively bred for high ethanol preference. Physiol Biochem Behav 35:385–390
Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM (1987) Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. J Pharmacol Exp Ther 243:666–673
Greenberg R, O'Keefe EH (1982) Thiorphan potentiation of stress-induced analgesia in the mouse. Life Sci 31:1185–1188
Hirning LD, Mosberg HI, Hurst R, Hruby VJ, Burks TF, Porreca F (1985) Studies in vitro with ICI 174864, (d-Pen2,d-Pen5)-enkephalin (DPDPE) and (d-Ala2, NMePhe4, Gly-ol)-enkephalin (DAGO). Neuropeptides 5:383–386
Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD (1986) Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39–54
Leander DJ (1983) A kappa opioid effect: increased urination in the rat. J Pharmacol Exp Ther 224:89–94
Leander DJ, Hart JC, Lochner MA, Hynes MD, Zimmerman DM (1982) Novel phenylpiperidine opioid antagonists and partial agonists: effects on fluid consumption. Eur J Pharmacol 81:185–192
Long JB, Ruvio BA, Glatt CE, Holaday JW (1984) ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: Pretreatment with dynorphin 1–13, a kappa agonist, blocks this action. Neuropeptides 5:291–294
Lorens AA, Sainati SM (1978) Naloxone blocks the excitatory effect of ethanol and chordiazepoxide on lateral hypothalamic self-stimulation behavior. Life Sci 23:1359–1364
Lumeng L, Hawkins TD, Li T-K (1977) New strains of rats with alcohol preference and nonpreference. In: Thurman RG, Williamson JR, Drott HR, Chance B (ed) Alcohol and aldehyde metabolizing systems, Vol III. Academic Press, New York, pp 537–544
Lumeng L, Doolittle DP, Li T-K (1986) New duplicate lines of rats that differ in voluntary alcohol consumption. Alcohol Alcohol 21:A125
Marfaing-Jallat P, Le Magnen J (1983) Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav 18:537–539
Miller L, Shaw JS, Whiting EM (1986) The contribution of intrinsic activity to the action of opioids in vitro. Br J Pharmacol 87:595–601
Murphy JM, Gatto GJ, Waller MB, McBride WJ, Lumeng L, Li T-K (1986) Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol 3:331–336
Paterson SJ, Robson LE, Kosterlitz HW (1983) Classification of opioid receptors. Br Med Bull 39:31–36
Paterson SJ, Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Robson LE (1984) Radioligands for probing opioid receptors. J Recept Res 4:143–154
Robson LE, Paterson SJ, Kosterlitz HW (1983) Opiate receptors. Handbook of Psychopharmacology 17:13–80
Roques BP, Fournie-Zaluski MC, Soroca E, Lecomte JM, Malfroy B, Llorens C, Schwartz JC (1980) The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288:286–288
Schulz R, Wuster M, Duka T, Herz A (1980) Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology 68:221–227
Schwartz JC, Costentin J, Lecomte JM (1985) Pharmacology of enkephalinase inhibitors. TIPS 6:472–476
Seizinger BR, Bovermann K, Maysinger D, Hollt V, Herz A (1983) Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol Biochem Behav 18:361–369
Snyder SH, Goodman RR (1980) Multiple neurotransmitter receptors. J Neurochem 35:5–15
White JD, Stewart KD, Krause JE, McKelvy JF (1985) Biochemistry of peptide-secreting neurons. Physiol Rev 65:553–606
Widdowson PS (1987) The effect of neurotensin, TRH and the delta-opioid receptor antagonist ICI 174864 on alcohol-induced narcosis in rats. Brain Res 424:281–289
Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
Wood PL (1982) Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology 21:487–497
Yaksh TL, Harty GM (1982) Effects of thiorphan on the antinociceptive action of intrathecal (DAa2, Met5) enkephalin. Eur J Pharmacol 79:293–297
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Froehlich, J.C., Zweifel, M., Harts, J. et al. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103, 467–472 (1991). https://doi.org/10.1007/BF02244246
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244246